OCCL Ltd
Incorporated in 2024, OCCL Ltd
is in the business of manufacturing
and selling of insoluble sulphur[1]
- Market Cap ₹ 478 Cr.
- Current Price ₹ 94.4
- High / Low ₹ 160 / 63.6
- Stock P/E 13.4
- Book Value ₹ 82.2
- Dividend Yield 1.59 %
- ROCE 14.9 %
- ROE 10.8 %
- Face Value ₹ 2.00
Pros
- Stock is trading at 1.15 times its book value
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|
| 0 | 0 | 307 | 446 | |
| 0 | 0 | 254 | 366 | |
| Operating Profit | -0 | -0 | 53 | 80 |
| OPM % | 17% | 18% | ||
| 0 | 0 | 2 | 3 | |
| Interest | 0 | 0 | 5 | 6 |
| Depreciation | 0 | 0 | 21 | 28 |
| Profit before tax | -0 | -0 | 29 | 48 |
| Tax % | -33% | -14% | 25% | |
| -0 | -0 | 21 | 36 | |
| EPS in Rs | 4.29 | 7.16 | ||
| Dividend Payout % | 0% | 0% | 35% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 333% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 382% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 6% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 11% |
Balance Sheet
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 10 | 10 |
| Reserves | -0 | -0 | 386 | 401 |
| 0 | 0 | 62 | 75 | |
| 0 | 0 | 76 | 85 | |
| Total Liabilities | 0 | 0 | 534 | 570 |
| 0 | 0 | 379 | 370 | |
| CWIP | 0 | 0 | 3 | 3 |
| Investments | 0 | 0 | 11 | 30 |
| 0 | 0 | 141 | 168 | |
| Total Assets | 0 | 0 | 534 | 570 |
Cash Flows
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0 | 70 | ||
| 0 | 4 | ||
| 0 | -74 | ||
| Net Cash Flow | 0 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 77 | ||
| Inventory Days | 188 | ||
| Days Payable | 77 | ||
| Cash Conversion Cycle | 189 | ||
| Working Capital Days | 67 | ||
| ROCE % | -86% | 15% |
Documents
Announcements
-
Board Meeting Intimation for Consider And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025.
29 Jan - Board meeting Feb 4, 2026 to approve Q3/9M unaudited results; trading window closed Jan 1, 2026.
-
Announcement under Regulation 30 (LODR)-Change in Management
27 Jan - VP Sales & Marketing Muneesh Batta resigned; relieved effective January 27, 2026.
-
General Announcement
7 Jan - Jan 6, 2026 BSE/NSE warning for no NRC meeting in FY2024–25; company cites exemption.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Jan
- Closure of Trading Window 23 Dec 2025
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
Demerger:[1][2]
OCCL was formed post business restructuring, wherein the chemicals business was demerged into OCCL Ltd and the investments (including the one in Duncan) remained with the parent company which is now renamed as AG Ventures Limited. A large portion of the investments was hived off to AG Ventures. The liquidity at OCCL Ltd. remains strong even as the company prepaid a sizeable portion of the long-term debt in Q1 FY25.